Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic

Brief Summary

Patients with acute renal colic divided into 2 groups. Group L administered ornoxicam and Group P administered pethidine and VAS was recorded for both groups.

Intervention / Treatment

  • Drug: Lornoxicam and mepridine

Condition or Disease

  • Renal Colic

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 20 Years to 60 Years   (Adult)
Enrollment: 120 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Jan 02, 2016
Primary Completion: Jul 17, 2020
Completion Date: May 18, 2020
Study First Posted: Dec 19, 2018
Results First Posted: Aug 31, 2020
Last Updated: Dec 21, 2018

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Location

Prospective, randomized, double blind clinical study including 120 patients with acute renal pain admitted in emergency department. They were randomly assigned to one of two groups using a computer-generated table. Group L received lornoxicam 8 mg IV plus 0.15 mg.kg-1 ketamine and Group P received pethidine 50 mg IV. Parameters were observed at baseline and after 0, 15, 30, 45 and 1 hour of drug treatment. The efficacy of the drug was measured by observing: patient rated pain, time to pain relief, rate of pain recurrence, the need for rescue analgesia, adverse events and functional status.

Eligibility Criteria

Sex: All
Minimum Age: 20
Maximum Age: 60

More Details

NCT Number: NCT03780556
Other IDs: ASU 5418
Study URL: https://ClinicalTrials.gov/show/NCT03780556
Last updated: Jan 28, 2021